Other Product Opportunities for BioCure's PVA Hydrogels

There are many other medical applications of BioCure's PVA hydrogels outside the area of embolics. We have made progress on the following applications. BioCure is interested in licensing these non-embolic products or finding partners for joint development or sponsored development.

:: Application :: Product :: Properties Tissue bulking agent for treatment of urinary incontinence and gastroesophageal reflux disease (GERD) Injectable in situ polymerizing hydrogel. Forms permanent, flexible hydrogel depot in tissue. Spray-on dressing for wounds, burns, ulcers. Spray-on in situ polymerizing hydrogel Forms strong hydrogel barrier film; potentially with active ingredients. Growth factor delivery to ulcers. Preformed or in situ polymerizing hydrogel dressing that releases the growth factor PDGF over 24 hours. Increases production of collagen by HDF. Wound healing using localized delivery of nitric oxide. Preformed or in situ formed hydrogel wound dressing that releases nitric oxide. Increases production of collagen by HDF. Prevention of restenosis and intimal hyperplasia with localized delivery of nitric oxide. Hydrogel coating for stents and grafts that releases nitric oxide and/or localizes cell adhesion peptides. Inhibits smooth muscle cell proliferation and platelet adhesion and promotes endothelial cell proliferation. Scaffolds for tissue regeneration and cell encapsulation. Preformed or in situ formed hydrogel substrate having cell adhesion peptides attached thereto. Supports biospecific cell adhesion and spreading.

Please contact us if you have any questions. We'd be happy to provide you with more information.